Overview

Update
Total Equity Funding
$5.7M in 1 Round from 4 Investors
Most Recent Funding
$5.7M Series C on May 10, 2010
Headquarters:
Mainz
Description:
Galantos Pharma is a drug development company focusing on new drugs for neurodegenerative diseases such as Alzheimer’s Dementia.
Founders:
,
Categories:
Biotechnology
Website:
http://www.galantos.com

Company Details

Update

Galantos Pharma GmbH focuses on the development of drugs for the treatment of Alzheimer's and other neurodegenerative diseases. It develops a drug for the treatment of mild-to-moderate Alzheimer's dementia. The company develops a technology platform that is suitable for screening and preclinical validation of drug candidates that are acting on cholinergic and other neuro-receptors and on various brain enzymes. The company was founded in 2005 and is based in Mainz, Germany.

Funding Rounds (1) - $5.7M

Update
DateAmount / RoundValuationLead InvestorInvestors
May, 2010$5.7M / Series C4

Current Team (2)

Update

Offices/Locations (1)

Update
  • Office

    Freiligrathstraße 12

    Mainz, 55131

    DEU

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos